Metabolism and Tissue Depletion of Carbadox in Swine, Broilers, and Rats

Jie Zhang,Wei Qu,Zongchao Wang,Yuanhu Pan
DOI: https://doi.org/10.1021/acsagscitech.1c00260
2022-01-01
ACS Agricultural Science & Technology
Abstract:Carbadox (CBX) has been used as an antimicrobial drug in the feed of swine for growth promotion and treatment of swine dysentery in young swine for decades. The marker residue (MR), quinoxaline-2-carboxylic acid (QCA), has been recommended by the Joint Expert Committee on Food Additives in 1990. However, there are several disputes that QCA is a reasonable target for monitoring the carcinogenic metabolites in the tissues of food-producing animals fed with CBX. In the present study, the mass balance and metabolism of CBX in swine, broilers, and rats have been investigated. After a single dose of 5 mg/kg b.w. of CBX by oral gavage, eight metabolites of CBX in the plasma and excreta were identified and characterized by liquid chromatography combined with ion trap and time-of-flight mass spectrometry and determined by a validated high-performance liquid chromatography method. The CBX metabolites, Cb3 (bisdesoxycarbadox, DCBX), Cb4, Cb7 (QCA), and Cb8 were higher than other metabolites in swine and rats. The drug was mainly eliminated through urine in swine and rats, and more than 90% of the dose was recovered within 24 h after treatment. Then, residue depletion studies were performed in swine and broilers after feeding them CBX-containing rations (50 mg/kg) for 15 consecutive days. The results showed that the total residues persisted for the longest time in the liver tissue, and the metabolites DCBX and QCA lasted for a longer time than other compounds. Moreover, DCBX has a t(1/2) of 2.54 d in swine liver, which is longer than that of QCA (t(1/2) = 2.24 d). Compared with QCA, DCBX should be a suitable MR for monitoring the residue of CBX in the food of animal origin, based on these results.
What problem does this paper attempt to address?